603739 Stock Overview
Engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Qingdao Vland Biotech INC. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.15 |
| 52 Week High | CN¥22.35 |
| 52 Week Low | CN¥7.70 |
| Beta | 0.35 |
| 11 Month Change | 1.78% |
| 3 Month Change | -5.19% |
| 1 Year Change | -4.29% |
| 33 Year Change | -18.63% |
| 5 Year Change | -29.76% |
| Change since IPO | 25.49% |
Recent News & Updates
Qingdao Vland Biotech INC.'s (SHSE:603739) Popularity With Investors Under Threat As Stock Sinks 26%
Jun 07
Investors Shouldn't Be Too Comfortable With Qingdao Vland Biotech's (SHSE:603739) Earnings
May 06Recent updates
Shareholder Returns
| 603739 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 10.6% | -2.5% | -0.8% |
| 1Y | -4.3% | -27.7% | -21.8% |
Return vs Industry: 603739 exceeded the CN Biotechs industry which returned -27.9% over the past year.
Return vs Market: 603739 exceeded the CN Market which returned -21.8% over the past year.
Price Volatility
| 603739 volatility | |
|---|---|
| 603739 Average Weekly Movement | 9.3% |
| Biotechs Industry Average Movement | 5.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 603739's share price has been volatile over the past 3 months.
Volatility Over Time: 603739's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 1,571 | Gang Chen | www.vlandgroup.com |
Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics.
Qingdao Vland Biotech INC. Fundamentals Summary
| 603739 fundamental statistics | |
|---|---|
| Market cap | CN¥3.33b |
| Earnings (TTM) | CN¥82.87m |
| Revenue (TTM) | CN¥1.25b |
40.2x
P/E Ratio2.7x
P/S RatioIs 603739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603739 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.25b |
| Cost of Revenue | CN¥677.06m |
| Gross Profit | CN¥576.07m |
| Other Expenses | CN¥493.20m |
| Earnings | CN¥82.87m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 45.97% |
| Net Profit Margin | 6.61% |
| Debt/Equity Ratio | 40.0% |
How did 603739 perform over the long term?
See historical performance and comparison